FORM 8-K
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): February 13, 2003 (February 13, 2003)

ENDO PHARMACEUTICALS HOLDINGS INC.

(Exact name of registrant as specified in its charter)

DELAWARE   39040   13-4022871
State or other   (Commission File Number)   (I.R.S. Employer
jurisdiction of       Identification No.)
incorporation)        

100 Painters Drive  
Chadds Ford, Pennsylvania 19317
(Address of principal executive offices) (Zip Code)

(610) 558-9800

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Table of Contents

Item 7. Financial Statements and Exhibits.

(a)   Financial Statements of Business Acquired.

     Not applicable.

(b)   Pro Forma Financial Information.

     Not applicable.

(c)   Exhibits.
         
Exhibit Number   Description
 
99.1
   Press Release of Endo Pharmaceuticals Holdings Inc. dated February 13, 2003

Item 9. Regulation FD Disclosure.

     On February 13, 2003, the Registrant issued a press release, a copy of which is filed herewith as Exhibit 99.1 and is incorporated herein by reference.

TABLE OF CONTENTS

SIGNATURES
INDEX TO EXHIBITS
PRESS RELEASE

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

       
  ENDO PHARMACEUTICALS HOLDINGS INC.
(Registrant)
      
  By: /s/ Carol A. Ammon
   
    Name: Carol A. Ammon
    Title:   Chairman & Chief Executive Officer

Dated: February 13, 2003

Table of Contents

INDEX TO EXHIBITS

     
Exhibit No.   Description
 
99.1   Press Release of Endo Pharmaceuticals Holdings Inc. dated February 13, 2003